Tri-Service General Hospital, National Defense Medical Center
Taipei, Taiwan
NCT Number: NCT04459039
BACKGROUND: Conventional hemorrhoidectomy leads to a high urinary retention rate and fluid restriction is commonly recommended to minimize complications. However, the need for postoperative fluid restriction among patients who have undergone stapled hemorrhoidopexy is unclear. We aimed to determine whether fluid restriction after stapled hemorrhoidopexy with/without partial external hemorrhoidectomy could reduce urinary retention and postoperative pain.
PATIENTS AND METHODS: In this prospective, double-blinded, randomized controlled trial, we enrolled patients who had grade III or IV hemorrhoids and underwent stapled hemorrhoidopexy with/without partial external hemorrhoidectomy; 250 mL/12 h of sterile 0.9% saline was administered to the fluid restriction group after the operation, and 1000 mL/12 h was given to the non-fluid-restriction group. We focused on the need for fluid restriction after stapled hemorrhoidopexy.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Interventional
Not applicable
Taipei, Taiwan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Within 12 h of surgery, the experimental group received 1000 mL 0.9% sterile saline intravenously.
Within 12 h of surgery, the control group received 250 mL 0.9% sterile saline intravenously.
Time frame: 1 day
the time to first urination after surgery
Tri-Service General Hospital (TSGH)
Other
Do We Need Fluid Restriction After Stapled Hemorrhoidopexy? A Pilot, Double-Blinded, Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04016311
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Austin, Texas, United States
View Trial DetailsNCT04232683
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Weston, Florida, United States
View Trial DetailsNCT05887375
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Columbia, Missouri, United States
View Trial DetailsNCT07304583
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Samsun, Atakum, Turkey (Türkiye)
View Trial Details